Clinical Trials Related to Mesothelioma

Related studies linked through entity extraction aliases.

Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen

Status: COMPLETED
Phase: PHASE2

Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma

Status: COMPLETED
Phase: PHASE2

A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma

Status: COMPLETED
Phase: PHASE3

Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers

Status: COMPLETED
Phase: N/A

Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma

Status: COMPLETED
Phase: PHASE2

Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (MK-0683-014)

Status: COMPLETED
Phase: PHASE3

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma

Status: COMPLETED
Phase: PHASE2

Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum

Status: TERMINATED
Phase: PHASE1

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma

Status: COMPLETED
Phase: PHASE2

ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.

Status: APPROVED_FOR_MARKETING
Phase: N/A

Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy

Status: COMPLETED
Phase: PHASE2